Market Place
Sourcing Support
Harmony Biosciences Buys Epygenix Therapeutics For Initial $35 Million
30 Apr 2024 //
PR NEWSWIRE
Epygenix Therapeutics to Participate in RW Baird`s Biotech Discovery Series
21 Jul 2022 //
PHARMIWEB
Epygenix Therapeutics Names Darren Cline as President and CEO
15 Mar 2022 //
CONTRACTPHARMA
Epygenix Therapeutics Announces FDA Acceptance of IND
30 Aug 2021 //
PRNEWSWIRE
EMA grants orphan medicinal product status to Epygenix Therapeutics’ EPX-200
02 Aug 2021 //
PHARMABIZ
Epygenix Announces First Patient Successfully Dosed in Phase 2 Study EPX-100
12 Nov 2020 //
PRNEWSWIRE
Epygenix Announces First Patient Successfully Dosed in Ph2 Study for EPX-100
11 Nov 2020 //
PRNEWSWIRE
Epygenix Therapeutics Announces First Patient Enrolled in Ph 2 EPX-100
02 Oct 2020 //
PRNEWSWIRE
Epygenix Therapeutics Initiates Phase 2 Study for Dravet Syndrome With EPX-100
17 Sep 2020 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.